C ardiovascular disease (CVD) is the main cause of morbidity and mortality in patients with end-stage renal disease (ESRD) (1, 2) or chronic kidney disease (CKD) (3) (4) (5) (6) (7) . The mechanisms underlying this increased cardiovascular risk are not clearly understood. In the general population, traditional risk factors for CVD have been well characterized (8) , and these are also present in CKD (3) (4) (5) (6) 9) . The mechanisms involved in the connection between CKD and CVD are probably numerous (3) (4) (5) (6) . Vascular calcification, such as coronary artery calcification (CAC) (10, 11) , is considered to be the causal link between them.
Vascular calcification is common in physiologic and pathologic conditions such as aging, diabetes, dyslipidemia, genetic diseases, and diseases with disturbances of calcium metabolism (12) (13) (14) . In CKD patients, vascular calcification is even more common, developing early and contributing to the markedly increased cardiovascular risk. Pathomorphologically, atherosclerosis (plaque-forming degenerative changes of the aorta and of large elastic arteries) and arteriosclerosis (concentric medial thickening and hyalinosis of muscular arteries) can be distinguished. Increased knowledge about the mechanisms of calcification together with improved imaging techniques have provided evidence that vascular calcification should be divided into two distinct entities according to the specific site of calcification within the vascular wall: plaque calcification, involving patchy calcification of the intima in the vicinity of lipid or cholesterol deposits, and calcification of the media in the absence of such lipid or cholesterol deposits, known as Mö nckeberg-type atherosclerosis (12) (13) (14) . These two types of calcification may vary in terms of the type of vessel affected, the location along the arterial tree (proximal versus distal), clinical presentation, and treatment and prognosis (12) (13) (14) . In the general population and in patients with CKD, electron-beam computed tomography (EBCT) has proven CAC as a potent predictor of cardiac events (15) (16) (17) (18) . Both the prevalence and intensity of CAC are increased in patients with CKD (19 -27) . Several studies have been undertaken to investigate whether calcification occurs in the intima or media of the coronaries and whether the morphologic details of calcified plaques differ between renal and nonrenal patients (12) (13) (14) 24) . Causal elements for either type of CAC have not been definitively determined (12) (13) (14) .
Autopsy studies are limited in terms of patient selection, but have a major advantage in terms of being able to distinguish intimal from medial calcification. Therefore, our primary goal is to determine whether, among autopsy subjects known to have CAD, there exists a direct relationship between level of kidney function and the prevalence of intimal or medial calcification.
Materials and Methods

Study Population
During the 6-yr period between 1991 and 1997, 699 subjects were autopsied at the National Cardiovascular Center, Osaka, Japan (28) . Given our goal of examining the coronary arteries, we limited autopsy cases to those with significant coronary artery disease (CAD), resulting in 123 remaining cases. To permit a pathologic study of the coronary arteries, we excluded six cases in which serum creatinine had not been measured. Thus, a final total of 117 autopsy subjects were reviewed histopathologicaly and immunohistochemicaly.
CAD included myocardial infarction and stable and unstable angina pectoris. Myocardial infarction was diagnosed using either electrocardiograms or echocardiograms, and angina pectoris was diagnosed based on both symptoms and electrocardiograms. Cerebral vascular disease was diagnosed using clinical history and computerized tomography findings. Peripheral vascular disease was diagnosed based on symptoms, an ankle/brachial pressure index of less than 0.9, or prior lower limb revascularization procedures. Thoracic or abdominal aortic aneurysm was diagnosed using clinical history and computed tomography. Smoking habits were recorded in two categories: current or former smokers, and nonsmokers. We possessed extensive laboratory data on all the study subjects, including serum creatinine, cholesterol, glucose, and urinalysis results. To create our dataset we chose the most representative data from the 3 mo before death. All laboratory values and medical information was obtained by chart review.
To define the presence of CKD, we applied the Modification of Diet in Renal Disease (MDRD) Study equation for evaluating Japanese CKD patients (29 -31) In the CKD5D group, the renal diseases that caused ESRD included nine cases of chronic glomerulonephritis, 11 cases of diabetic nephropathy, and three cases of nephrosclerosis. The mean duration (Ϯ SD) of hemodialysis therapy was 43 Ϯ 60 mo.
Causes of death among all subjects were coronary heart disease in 67% of cases, cerebrovascular disease in 9%, aortic aneurysm in 9%, infection in 10%, and other causes in the remaining 5%.
Pathologic Examination of Coronary Arteries
In accordance with the regulations of our pathology department, the all autopsy examination was performed within 3 h after patient's death. The coronary arteries were perfusion-fixed for 2 h with neutral buffered formalin at 100 mmHg and then studied by subserial sectioning at 4 mm intervals. These sections were sliced 5 m thick on glass slides and stained. We studied all sections with or without significant stenosis of the proximal and distal right coronary artery (RCA), left main coronary artery, proximal and distal left anterior descending (LAD) coronary artery, and proximal and distal left circumflex (LCX) coronary artery. Apparent stenosis of a coronary artery with more than 75% narrowing of the luminal area was considered significant.
We used the American Heart Association histologic classification of atherosclerosis (32) to identify type V lesions that manifested as calcified plaques. Histologic calcification of the intima and media was detected using Hematoxylin and eosin (HE) staining and osteopontin immunostaining. To determine the extent of calcification, coronary artery sections were evaluated using a 5-point scale: grade 0, no calcification; grade 1, calcification Ͻ25% in cross-sectional area; grade 2, calcification Ͼ25% and Ͻ50% in cross-sectional area; grade 3, calcification Ͼ50% and Ͻ75% in cross-sectional area; grade 4, calcification Ͼ75% in cross-sectional area. To detect inflammation, immunostaining for CD68-positive macrophages was performed.
Statistical Analyses
Values are represented as means Ϯ SD with a p-value of Ͻ0.05 as significance. To compare the variables, one-way ANOVA and chisquared tests were used. The association between risk factors and calcification of coronary arteries was determined by logistic regression The authors had full access to the data and take responsibility for its integrity. All authors have read and agree on the manuscript as written. Table 1 shows the baseline characteristics. The mean age was higher in the CKD3 and CKD4/5 groups. Hypertension was evident in the CKD4/5 and CKD5D groups. Diabetes was infrequent in the patients without CKD. Incidence of smoking, CAD, CVD, peripheral vascular disease, and aortic aneurysm were not different among the groups. Serum albumin concentration was lower in the CKD4/5 and CKD5D groups. CRP data were higher in the CKD4/5 and CKD5D groups. The prescription of phosphate binders was more frequent in CKD5D groups. The use of statins, vitamin D, and warfarin, which may affect vascular calcification, was not different. Table 2 shows the degree of luminal stenosis of coronary arteries, and the stenosis was severe in CKD4/5 group. Figure  1 shows representative sections of coronary arteries. In the CKD5D group, severe stenosis in the proximal segment was composed of an atheromatous plaque containing a large area of intimal calcification (Figure 1A) , and distal segment showed also severe stenosis with calcified plaque (Figure 1B) . In a patient without CKD we observed a large necrotic core with f P Ͻ0.01. Versus CKD4: g P Ͻ0.05, h P Ͻ0.01. Coronary arterial sections were evaluated regarding extent of calcification using a 5-point scale: grade 0, no calcification; grade 1, calcification Ͻ25% of cross-sectional area; grade 2, calcification Ͼ 25% and Ͻ50% of cross-sectional area; grade 3, calcification Ͼ50% and Ͻ75% of cross-sectional area; grade 4, calcification Ͼ75% of cross-sectional area. Figure 1D ), without severe stenosis of distal segments ( Figure 1E ). Using immunohistochemical staining, osteopontin-positive calcified plaque was found in the atheromatous plaque of the intima at the proximal segment in the CKD5D group ( Figure 1C) , and an accumulation of CD68-positive macrophages was seen in an atheromatous plaque with lymphocyte infiltration ( Figure 1F ).
Results
Patient Characteristics
Histopathology of Coronary Arteries
Intimal Plaque Calcification and Risk Factors
Intimal calcification was most evident in groups CKD5D, CKD4/5, and CKD3 (Table 3) . Table 4 shows the intimal calcification score in each segment of the coronary arteries. Calcification was higher in the CKD5D group than in the other groups. The scores were also high in the CKD4/5 group, in the proximal and distal RCA lesions and proximal LCX coronary artery lesion.
Univariate analysis was performed to assess the presence of intimal calcification (Table 5) . Stenosis, hemodialysis, and kidney function seemed to be linked to intimal calcification in almost all cases. Smoking was linked to calcification of proximal lesions, while calcium-phosphorus product or phosphate binder use was linked to calcification of distal lesions. Diabetes, age, and inflammation seemed to be linked to calcification of both of proximal and distal lesions. The use of vitamin D was not linked to calcification, but warfarin administration tended to relate the coronary calcification.
Multivariate analysis for the presence of intimal calcification was performed based on the logistic regression analysis ( Table  6 ). The significant variables were kidney function, luminal stenosis, and age.
Medial Calcification and Risk Factors
We evaluated calcification in media of coronary arteries in all subjects. Medial calcification was present in CKD4/5 and CKD5D groups, in proximal lesions of four cases and distal lesions of three cases among 39 cases. Medial calcification of both proximal and distal lesions was seen in the segments with or without intimal calcification, and the continuous deposit of intimal calcification into the media was not observed. The area of medial calcification occurred Ͻ25% of the total medial area in the proximal lesions of three patients and in the distal lesions of two patients. One patient showed medial calcification Ͼ75% of the total medial area in both proximal and distal lesions, who had severe CAD and more than 20 yr duration of hemodialysis.
We performed univariate analysis to assess the presence of medial calcification. The only significant variable associated with medial calcification in proximal lesions was the use of calciumcontaining phosphate binders (RR 21.0, 95% CI 1.9 to 236.1, P Ͻ0.05), while for distal lesions significant variables were hemodialysis treatment (RR 5.1, 95% CI 1.2 to 39.4, P Ͻ 0.05) and hemodialysis duration (RR 1.05, 95% CI 1.01 to 1.15, P Ͻ 0.05).
Discussion
We evaluated the pathologic findings of coronary arteries focusing on locality and severity of calcification in autopsy cases known to have CAD and a wide range of kidney function. Our results showed that: (1) calcification of coronary arteries was deposited intimal plaque mainly in all cases but also medial layer among cases of CKD4/5 and CKD5D; (2) intimal plaque calcification was more severe in patients who had received hemodialysis than in those who did not; (3) intimal calcification was more intense in patients with an eGFR below 30 ml/min/1.73 m 2 than in CKD patients with an eGFR over 60 ml/min/1.73 m 2 or in patients without CKD; (4) intimal calcification was associated with both traditional cardiovascular and uremic risk factors; and (5) medial calcification was present in CKD4/5 and hemodialysis cases, with incidence increased by the presence of uremic risk factors.
Calcification may arise in all types of arteries, both large elastic vessels and smaller muscular ones. The location and degree of vascular calcification depend on physiologic and pathologic conditions (12) (13) (14) . Calcification develops earlier than otherwise might in the absence of severe CKD, and contributes to the markedly increased cardiovascular risk observed in this particular population (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . The CAC is thought to occur in two types in the vessel wall. There is still debate about whether these two types of calcification are distinct entities or not (12) (13) (14) . London et al. found that typical plain x-ray aspects in CKD patients showed either a patchy distribution, which is thought to be characteristic of intimal calcification in association with atherosclerosis, or a pipeline-like distribution attributed to medial calcification (33, 34) . However, in many patients with ESRD these two processes seem to develop in parallel (12) . Although the entire vascular tree may calcify, only some segments develop atherosclerosis, including the coronary arteries, the aorta, and the arteries of the abdomen and lower extremities (12) . In contrast, for example, the arteries of the upper extremities, appear relatively or entirely resistant to the atheromatous process (12) .
Intimal and medial calcification is thought to differ with regard to their clinical relevance. Whereas intimal calcification appears to contribute to plaque vulnerability, possibly in a biphasic manner, medial calcification contributes to vascular stiffness, which increases pulse-wave velocity and decreases diastolic BP and increases systolic BP (35) . Hemodialysis patients with predominantly intimal calcification have a higher relative risk of mortality than those with predominantly medial calcification (34) . However, presently available noninvasive im- (27) . Garlannd et al. reported that in patients with stages 3, 4, and 5 CKD without cardiovascular disease, traditional cardiovascular risk factors and serum calcium levels were associated with CAC, while no association was shown with eGFR (25) . The range of kidney function was wider in our study than in those mentioned above (25, 27) , enabling us to evaluate the association between CAC and kidney function. Indeed, no association was found in several segments in our study in CKD3, CKD4/5, or CKD5D patients. These findings showed that intimal calcification had already started before kidney function reached CKD3, and after reaching CKD3 the degree of calcification developed significantly. The finding of Go et al. that eGFR below 45 ml/min was a risk factor for cardiovascular mortality (36) may be associated with the presence of intimal calcification of CKD3 patients.
We demonstrated that medial calcification occurs in CKD4/5 and CKD5D patients with known CAD, in coronary sections with and without significant stenosis or intimal calcification. The medial calcification was not due to the continuous deposition of intimal calcification into the media. This finding was more evident in hemodialysis patients without significant stenosis or intimal calcification (unpublished data). This observation may support the hypothesis that mechanism of both types of calcification would be different. We cannot conclude that no association was present between medial calcification and atheromatous plaque formation. Medial calcification was associated with hemodialysis therapy, but not with stenosis of arteries. We identified the different risk factors for intimal and medial calcification; for medial calcification, these included uremic risk factors.
One limitation of our study is that we analyzed only autopsy subjects known to have CAD, most of whom died of cardiovascular diseases, and did not examine any subjects without CAD. Our autopsy study was necessarily performed using a chart review to obtain each individual's clinical history, potentially introducing a degree of ascertainment bias. A second source of potential bias in this study is the use of estimated GFR. At higher GFR levels, the value may be underestimated, an issue common to all populations.
In conclusion, we have demonstrated the presence and associations of CAC in patients with CAD and a wide variation in kidney function. Traditional and nontraditional risk factors were applicable to CAC in patients with CAD and CKD. Kidney function, smoking, diabetes, calcium-phosphorus metabolism, and aging were risk factors for intimal calcification. Medial calcification was strongly suspected to relate to uremic risks. We should attempt to control both types of risk factors to prevent the onset of CAC before stage 3 CKD.
